AI/ ML will revolutionize medicine by making diagnosis and treatment more accessible and more effective.
FDA has regulated medical software by means of regulations and guidance for years, however, AI/ML programs fall outside the scope of these regulations and guidances.
This happens because FDA approves the final, validated version of the software. The point of AI/ML is to learn and update following deployment to improve performance. Thus the field version of the software is no longer the validated approved version.
We will discuss the current regulatory requirements, how they don’t control AI/ML adequately, and approaches FDA is considering for regulation in the near future. Your development program should conform to these concepts now because, with some modifications, they will probably become regulations.
Following a discussion of possible future regulations, we will discuss, based on recently approved De Novo applications, how to get your AI/ML program approved now. Necessary submission documentation will be explained.
This webinar is not a programming course but will explain the present and future regulatory requirements for AI/ML.
WHY SHOULD YOU ATTEND?
- It is not clear how to get AI/ML programs approved. The current regulatory requirements don’t control AI/ML adequately.
- We will discuss the approaches FDA is considering for regulation in the near future and how to get your AI/ML program approved by FDA now.
- Necessary submission documentation will be explained Attendees will receive a multipage outline and checklist.
AREA COVERED
- Total product life cycle approach to AI/ ML design
- Application of FDA software Pre Cert program to AI/ ML
- FDA discussion paper on AI/ML
- Database management
- QC of datasets
- Algorithm updating
- Reference standard development
- Standalone performance testing
- Clinical performance testing
- Data Enrichment
- Emphasis on "explainability"
- Additional labeling requirements
- Cybersecurity
WHO WILL BENEFIT?
Managers, Supervisors, Directors, and Vice-Presidents in the areas of:
- Software Engineers
- Engineers
- Regulatory Personnel
- Quality Assurance Personnel
- Marketing
- Management
- It is not clear how to get AI/ML programs approved. The current regulatory requirements don’t control AI/ML adequately.
- We will discuss the approaches FDA is considering for regulation in the near future and how to get your AI/ML program approved by FDA now.
- Necessary submission documentation will be explained Attendees will receive a multipage outline and checklist.
- Total product life cycle approach to AI/ ML design
- Application of FDA software Pre Cert program to AI/ ML
- FDA discussion paper on AI/ML
- Database management
- QC of datasets
- Algorithm updating
- Reference standard development
- Standalone performance testing
- Clinical performance testing
- Data Enrichment
- Emphasis on "explainability"
- Additional labeling requirements
- Cybersecurity
Managers, Supervisors, Directors, and Vice-Presidents in the areas of:
- Software Engineers
- Engineers
- Regulatory Personnel
- Quality Assurance Personnel
- Marketing
- Management
Speaker Profile
Edwin Waldbusser, is a consultant retired from industry after 20 years in management of development of medical devices (5 patents). He has been consulting in the areas of design control, risk analysis and software validation for the past 8 years. Mr. Waldbusser has a BS in Mechanical Engineering and an MBA. He is a Lloyds of London certified ISO 9000 Lead Auditor and a member of the Thomson Reuters Expert Witness network.
Upcoming Webinars
California Meal and Rest Breaks: What You Dont Know Can Cos…
Responding to EEOC Discrimination Charges-What's Your Busin…
Implementing an Effective Human Error Reduction Program
Conflict Resolution - Prevent, De-escalate, Resolve
When Employees Travel: Wage and Expense Rules Employers Mus…
With Mandatory Paid Leave Gaining Ground Is It Time To Do A…
Female to Female Hostility @Workplace: All you Need to Know
Form 1099-MISC and 1099-NEC Compliance Update 2024
Validation Statistics for Non-Statisticians
The Totally Organized Professional Is All About Outcomes
Why EBITDA Doesn't Spell Cash Flow and What Does
GAMP5, Second Edition and Alignment with Computer Software …
Project Management for Non-Project Managers - Scheduling yo…
Sunshine Act Reporting - Clarification for Clinical Research
Understanding the Math of HR… So You Can Show How HR Impact…
FFIEC BSA/AML Examination Manual: What Compliance Officers …
How to Address ISO's New Climate Change Requirements
I-9 Audits: Strengthening Your Immigration Compliance Strat…
Re-imagine Finance & Accounting Made Simple. Three Webinars…
Stay Interviews: A Powerful and Low-Cost Employee Engagemen…
How To Conduct An Internal Harassment And Bullying Investig…
Effective Onboarding: How to Welcome, Engage, and Retain Ne…
Managing Toxic & Other Employees Who Have Attitude Issues
Analytical Method Validation Under Good Laboratory Practic…
Do's and Don'ts of Documenting Employee Behaviour, Performa…
Do's and Don'ts of Giving Effective Feedback for Performanc…
Onboarding New Hires: Leverage the Potential of Artificial …
Project Management for HR, Administrative Professionals, an…
Tattoos, hijabs, piercings, and pink hair: The challenges …
Using Behavior Based Interviewing for Finding the Best Matc…
How to Document Employee Discussions and Why it is Important
Stressed Out: How to Handle Conflict, Difficult People and …
Harassment, Bullying, Gossip, Confrontational and Disruptiv…
Best Practices for Working With Vendors and Suppliers
Understanding the Artificial Intelligence Landscape
Marketing to Medicare or Medicaid Beneficiaries - What You …
Accounting For Non Accountants : Debit, Credits And Financi…
Principles & Practices for the Cybersecurity of Legacy Medi…
Independent Contractor vs. Employee New Rule Issued by The …
Ultimate Persuasion Strategies! - Secret Influence Tools & …
Kicking your Employee Retention Efforts into Overdrive: Sta…